Burkitt's lymphoma (BL) in
Introduction
Epstein-Barr virus (EBV), a ubiquitous human herpesvirus, has been thought to be involved in the pathogenesis of a wide variety of neoplasms including endemic Burkitt's lymphoma (eBL), 1 nasopharyngeal carcinoma (NPC), 1,2 Hodgkin's disease (HD), 3 lymphoma in immunocompromised patients, 4, 5 and peripheral T cell lymphomas (PTLs). 6 Diseases associated with EBV infection have an unusual geographic distribution. NPC is mostly confined to Southeast Asia and is consistently associated with EBV. Multiple copies of the EBV episome have been found in all poorly differentiated or anaplastic NPCs, regardless of geographic origin. 2 In Europe and North America, NPC is a rare disease. eBL is mostly localized in equatorial Africa where endemic malaria is prevalent and shows the strongest and most consistent association with EBV. Virtually all the malignant cells in the tumor are EBV genomepositive, and each tumor carries a monoclonal EBV episome. 7 In contrast to eBL, the sporadic BL (non-African or American), which occurs world-wide but is best characterized in Europe and the USA, where its incidence is only around 20% of cases are EBV-associated. 8, 9 Besides ethnic factors which may influence the prevalence of EBV-associated tumors in different countries, EBV strain variation may also contribute to this geographic distribution of the disease.
In nature, EBV isolates collected worldwide exhibit general sequence homology and conservation of restriction endonuclease sites throughout the genome. However, significant strain-or type-specific differences occur in the regions encoding EBNA-2, EBNA-3, and the two nonpolyadenylated small RNA (EBER) of EBV with divergent evolutionary origins. [10] [11] [12] [13] [14] [15] [16] Analysis of the DNA around the EBNA-2-encoding region in several strains defined two types (A and B) of EBV, which encode antigenically distinct forms of EBNA-2. 10, 12, 17 Previous reports indicated that type A EBV is predominant in Western countries, in contrast to type B, which has been found mainly in central Africa and in New Guinea. 18, 19 Cell lines containing type A virus had significantly higher growth rates and achieved much higher saturation densities than did type B strains. 20 EBV LMP-1 is a transforming oncogene in rodent fibroblasts Rat-1 21 and Balb/3T3 cells. 22 An alteration of the XhoI restriction enzyme site in codon 17 of exon 1 of the LMP-1 gene provides a restriction fragment length polymorphism marker that distinguishes EBV strains of Chinese NPC from those of African NPC. 23 Furthermore, a 30-bp deletion and seven single-base mutations in the C-terminal part of the LMP-1 gene were found in Chinese NPC CAO cell line. 23 We recently reported that a specific G to C transversion at the first base of codon 18 of exon 1 was consistently observed in EBV isolated from Italian Hodgkin's lymphoma. 24 These findings suggested that the variant of EBV preferentially associated with Chinese NPC was different from that associated with Italian Hodgkin's lymphoma.
The clinical presentation, the primary disease site, chromosomal breakpoint, and epidemiological features differ between different forms of BL. eBL is classically a childhood malignancy with an unusual pattern of presentation at extranodal sites, most frequently in the jaw, sometimes in the orbit, central nervous system, or as an abdominal mass. Sporadic BL has a different pattern of presentation, more frequently involving the abdomen and very rarely the jaw or orbit; bone marrow is also commonly involved. Previously, we reported that the BL in Turkish children is a form intermediate between eBL (African type) and sporadic BL (American type). [25] [26] [27] To provide insights into the molecular mechanisms underlying the pathogenesis of the EBV associated with BL of Turkish children, we evaluated sequence variation within the C-terminus of the LMP-1 gene and performed genotyping to determine its relation to sequence variation. In this and our previous reports [25] [26] [27] we have found a strong association (93%) of EBV infection in Turkish BL, which is very similar to African BL, but different from western BL, which has a very low level of association with EBV. We have also found that all EBVpositive Turkish BLs were infected by type A virus. Our results further indicate that the BL of Turkish children is infected by the EBV strain with mutated LMP-1 gene that is similar but not identical to the Asian NPC CAO strain. The Asian NPC CAO strain contains a 30-bp deletion in the C-terminus of LMP-1 gene, whereas the EBV in BL of Turkish children contains, in addition to the 30-bp deletion detected in CAO strain, a predominant 69-bp deletion in the same region of the LMP-1 gene.
Materials and methods

Tumor samples
The Burkitt's lymphoma (BL) tissues were obtained from the Department of Pediatric Oncology, Ankara University Medical School and Dr Sami Ulus Children's Hospital. Thirty paraffin-embedded tissue blocks from children (mean age 5.9 years) with BL were selected for this study.
Tissue section preparation
Excess paraffins were trimmed from the block and sections (10 m) were sliced by a microtome. Depending on the size of the tissue, five to 10 sections were pooled and transferred into a 1.5-ml microfuge tube. To avoid cross-contamination of samples, the microtome blade, tweezers, and the cutting area were carefully cleaned with xylene. A clean new blade was used for each block.
Deparaffinizing sections
To remove the paraffin, tissue sections were extracted twice with octane by soaking in approximately 1 ml of octane and incubating for 30 min at room temperature. The tissues were pelleted by centrifugation for 5 min at full speed in microfuge. Residual octane was removed by washing the tissues with approximately 0.5 ml of 100% ethanol. The tissues were pelleted by centrifugation and the ethanol removed. Tissue samples were dried under vacuum until the residual ethanol had completely evaporated.
Isolation of DNA
Depending on the size of the sample, 50-100 l of lysis buffer (10 mM Tris-HCl, pH 8.5, 1% 10 lauryl ether and 200 g/ml proteinase K) were added to the samples. The mixtures were incubated at 55°C overnight, followed by heating at 95°C for 8 min. The samples were centrifuged for about 30 s to remove any residual paraffin or tissue. An aliquot (10 l) of supernatant was used for subsequent PCR amplification.
Nested PCR amplification of the LMP-1 gene of EBV
The strategy to amplify the DNA sequences spanning the 30-bp deletion and 33-bp repeat regions of the C-terminus of the LMP1 gene is depicted in Figure 1 . We selected an outer primer pair (P1/P2) that encompasses a 594-bp fragment bracketing the 33-bp repeat and 30-bp deletion regions of the C-terminus of the LMP1 gene. Two inner primer pairs were selected, one pair (P3/P4) to amplify the 33-bp repeat region and the other pair (P5/P6) to amplify the 30-bp deletion region. The location and sequence of the primers and probes are shown in Table 1 . The conditions and parameters for amplification of the EBV DNA sequences by PCR were as described previously. 28, 29 Briefly, aliquots of genomic DNA were amplified in a total reaction volume of 0.1 ml according to the manufacturer's protocol (Perkin-Elmer/Cetus, Norwalk, CT, USA). The mixtures were subjected to 35 cycles of amplification (30 s at 94°C, 30 s at 57°C and 1 min at 72°C) in a thermal cycler (Perkin-Elmer/Cetus). Before cycling, the samples were denatured at 94°C for 5 min. After the last cycle, the polymerization step was extended by 10 min. Ten microliters of the PCR-amplified product with primer pair P1/P2 were used as the template for the subsequent nested PCR using either primer pair P3/P4 to amplify the 33-bp repeat region or P5/P6 to amplify the 30-bp deleted region. The conditions and parameters for nested PCR were the same as in the unnested PCR.
Agarose gel electrophoresis and Southern blot
PCR-amplified products were analyzed by 2% agarose gel electrophoresis and Southern blotted onto a Hybond-N paper (Amersham, Arlington Heights, IL, USA). After blotting, DNA was UV cross-linked to the filter and the filter was baked in a vacuum oven at 80°C for 30 min. The sheet was hybridized with an internal probe labeled with 32 P at the 5Ј-end and exposed to Kodak X-ray film.
EBV genotyping
The primers selected to amplify the strain-specific variations in EBNA-2 and EBNA-3C gene loci have been reported previously. 28 The location and sequence of the primers and probes are shown in Table 2 . The conditions and parameters for PCR amplification were the same as those for LMP-1 described above.
Direct DNA sequencing of PCR products
PCR products were electrophoresed through 2% low-melting point agarose gels, and the expected fragments were localized and excised. The gel slices were transferred to a Spin-X column with a 0.45 m cellulose acetate filter (Costar, Cambridge, MA, USA) and centrifuged for 15 min in a microfuge. The supernatant was ethanol precipitated and the DNA pellet was suspended in a small volume of water. The purified DNA was then sequenced directly with the ABI Prism 373 DNA Sequencer by using the ABI Prism Dye Terminator Cycle Sequencing Core Kit (Perkin-Elmer Corporation, Applied Biosystems Division, Foster City, CA, USA).
Figure 1
The carboxy terminus of the LMP-1 gene. The locations of the primer and probe are shown (Table 1) . A 30-bp deletion in a Chinese EBV strain (CAO) and the 33-bp variable repeat region are indicated. Table 1 Location and sequence of primers and probes for nested PCR amplification of LMP-1
Primer (coordinate a ) Nucleotide sequence
The coordinates are based on the sequence of B95-8 prototype strain. The size of the products amplified by P1/P2 are 594 bp and 564 bp in the B95-8 and CAO strain, respectively; by P3/P4 are 222 bp and 250 bp in AG876 and B95-8, respectively; by P5/P6 are 196 bp in B95-8 and 166 bp in CAO. Probe 1 can be used to hybridize the PCR products of P1/P2 and P3/P4, whereas probe 2 is used to hybridize the PCR products of P5/P6.
Table 2
Location and sequence of primers and probes for PCR amplification of EBNA-2 and EBNA-3C
Primer ( 
Results
Nested PCR amplification of LMP1 gene
To improve the sensitivity of detection of EBV in limited amounts of DNA isolated from paraffin-embedded tissue sections, we designed primer pairs for nested PCR amplification.
In the first round of unnested PCR amplification, only a few samples were positive for the 594-bp fragment (data not shown). When aliquots of the unnested PCR products were used as the target template and amplified with inner primer pair (P3/P4) for the 33-bp repeat region, variable sizes ranging from 200 to 300 bp were observed (Figure 2 ). This inner primer pair amplified an expected size (222 bp) of fragment from AG876 strain (Figure 2, lane 19 ) and a fragment of approximately 250 bp from the prototype B95-8 ( Figure 2 , lane 18). It has been reported 30 that both AG876 and B95-8 contain four complete copies and one incomplete copy of the 33 bp/11 amino acid repeat element. B95-8, however, contains a 15-bp insertion in its third repeat relative to AG876 and this 15-bp sequence appears to have been duplicated. 30 Interestingly, heterogeneous sizes of fragments were observed Nested PCR amplification of the 33-bp variable repeat region. The primer pair (P1/P2) was used for the first round of amplification and the product was a 594-bp fragment, which was used as the target DNA for the subsequent nested PCR amplification using inner primer pair (P3/P4) to amplify the 33-bp variable repeat region. Lanes 1-17 are BL samples with different copy numbers of the repeat ranging from 4.5 to 7; lane 18, B95-8 (4.5 copies); lane 19, AG876 (4 copies); lane 20, negative water control. The autoradiogram was obtained by Southern blot hybridization using Pb1 as probe. The sample numbers correspond to the case numbers in Table 3 and in the DNA sequence data labeled BL1 to BL22 in Figure 5. in the BL samples (lanes 1-17) , reflecting the different copy numbers (ranging from 4.5 to 7) of the 33-bp repeat in these EBV isolates.
Similarly, amplification with the inner primer pair (P5/P6) for the 30-bp deletion region also resulted in variable sizes ranging from 127 to 196 bp. As expected, a fragment of 196 bp was amplified from B95-8 DNA (Figure 3, lane 15) , in contrast to 166 bp from AG876 (lane 16), which is 30 bp shorter in this region. 30 However, different sizes of fragment smaller than 196 bp were observed in BL samples ( Figure 3,  lanes 1-14) . For example, the amplified products from samples in lanes 3, 10, 12 and 14 were 127 bp; fragments in lanes 2, 8 and 11 were the same size as B95-8 (196 bp) and those in lanes 6 and 13 were the same size as AG876 (166 bp). Interestingly, a doublet, one band of approximately 127 bp and the other 166 bp, were amplified from samples in lanes 1 and 4. The specificity of these amplified fragments were confirmed by Southern blot hybridization using an internal probe (data not shown). The differences in size due to deletion were later confirmed by direct DNA sequencing analyses. No apparently visible bands were detected in lanes 5, 7 and 9. However, they became detectable after concentration of the sample and their sizes were all 127 bp (data not shown). With the nested PCR, we detected 28 (93%) of 30 BL specimens positive for LMP-1; the EBV positivity (93%) was further confirmed by EBV genotyping described below.
EBV genotyping
To assess whether the alteration of the C-terminus of the LMP-1 gene is associated with a specific genotype, EBV genotyping was carried out by PCR 28 using primer pairs 16 shown in Table  2 . Figure 4 shows representative results of genotyping with EBNA-3C. All 28 EBV-positive patients were infected by type A virus. The results of genotyping and DNA sequencing analyses are summarized in Table 3 .
DNA sequencing analysis
To assess whether the variable size of PCR-amplified fragments reflected differences in the size of deletion within the segment bracketed by the primer pair (P5/P6), we purified the fragments and directly sequenced them. When compared with the prototype (B95-8), four patterns of size distribution are observed: the first (32% (9/28)) identical to B95-8 with no deletion, the second (11% (3/28)) identical to Asian NPC CAO strain with a 30-bp deletion, the third (46% (13/28)) prevalent in Turkish BLs with a longer deletion (69 bp), and the fourth (11% (3/28)) consisting of a mixture of 30 bp-and 69 bpdeletion (see Table 3 and Figure 5) . A detailed comparison of DNA sequences between B95-8, CAO and representative cases of BL are shown in Figure 5 .
Discussion
Recent reports indicate that EBV LMP-1 gene polymorphisms may be specifically associated with some virus-positive tumors and may confer a more aggressive malignant phenotype. 31, 32 Cloning and sequencing of the LMP-1 gene of EBV from Chinese NPC biopsies have identified several mutations as compared with the prototype B95-8 strain, including a 
Table 3
Sequence analysis of C-terminus of LMP1 gene and genotype of EBV from BL of Turkish children
Case
Disease site Deletion and status 30 bp 69 bp 30 None Genobp/69 type bp
Abd, Liv, Jaw, Kid, 3y, R
Ple, 3y
Abd, Tes, 11y, R
Abd, Jaw, Tes, 8y, R
Abd, Thy, 4y,
Abd, Asc, Bon, 9y, R
Abd, Jaw, Liv, 3y, D
Four patterns of size distribution are observed: the first (32% (9/28) identical to B95-8 with no deletion, the second (11% (3/28)) identical to Asian NPC CAO strain with a 30-bp deletion, the third (46% (13/28)) prevalent in Turkish BLs with a longer deletion (69 bp), and the fourth (11% (3/28)) consisting of a mixture of 30-bp and 69-bp deletion. Abd, abdomen; Asc, ascite; Kid, kidney; Liv, liver; Ple, pleural fluids; Tes, testis; Nec, neck; Thy, thyroid; bon, bone; y, year; R, remission; D, decease; L, lost to follow-up; NA, not available.
point mutation leading to the loss of an XhoI restriction site in the first exon and a 30-bp deletion in the carboxy terminal region of the LMP-1 gene. 23 Although the LMP-1 protein is expressed in the majority of cases of NPC and HD (latency II), the protein is not typically expressed in BL (latency I). This raises the doubt whether the presence of LMP-1 deletions could be of any importance in the pathogenesis of BL. Recent studies, by the immunohistochemical method, indicate that LMP-1 proteins were detected in a few cases of BL; the majority of cases were negative. 33, 34 Thus, it has been postulated 33 that LMP-1 protein is expressed and is important only during neoplastic transformation, and is no longer expressed at a later time, as it may not be critical to maintenance of the neoplastic state. In addition, our unpublished results indicate that CD44, ICAM-1 and LFA-1 were expressed in some of the Turkish BL, characteristic of latency III phenotype. Because of the central role of LMP-1 in the development of EBV-associated tumors and its effects on cell growth, delineation of sequence variation of the LMP-1 gene and its relation to genotype is relevant to understanding the biology and genetics of the naturally occurring isolates. We have therefore determined the nucleotide sequences of C-terminus of the LMP-1 gene derive from Turkish BL viral isolates and have compared them to the sequences of B95-8 and Chinese NPC CAO strains. Analyses of DNA sequence of 28 Turkish BLs have disclosed four patterns: the first identical to that of B95-8 strain with no deletion, the second identical to Asian NPC CAO strain with a 30-bp deletion, the third prevalent in Turkish BLs with a longer deletion (69 bp), and the fourth consisting of a mixture of 30 bp-and 69 bp-deletion. The mixture of 30-bp and 69-bp deletion detected in three patients (see Figure 3 and Table  3 ) could result from dual infection by a virus mixture representing Asian and Turkish variants based on the deletion pattern in the LMP-1 gene. Genotyping analysis has shown that type A virus was the only strain detected in these BL patients, indicating the predominance of type A virus in this population.
Upon inspection of the sequence variations, a striking feature was observed. The most conspicuous point mutations detected in the BL samples of Turkish children were clustered at the amino acids 322, 334, 338 and 342 where the triplet codons were also altered in strain CAO, an EBV strain isolated from a Chinese NPC. Several mutations specific for Turkish BL were clustered at amino acids 326, 352 and 361. In those BL cases without deletion, sporadic changes in triplet codon were found at amino acids 321, 323, 327, 331, 349, 354, 356
Figure 5
Comparison of DNA sequences of EBV strains B95-8, CAO, and BLs of Turkish children. The detailed DNA sequences from 22 BLs are shown for amino acids 320-361. CAO, an Asian EBV strain from NPC patient; B95-8, a prototype; BL1-BL22 correspond respectively to case numbers 1-22 listed in Table 3. and 357. In addition to some specific changes characteristic for Turkish BL, in general the DNA sequences from Turkish BL were different from the prototype (B95-8), but similar to the Asian strain (CAO) with respect to the mutation profile and deletion, even though the deletion was shorter in the CAO (30 bp). It should be noted that in all the isolates with the 69-bp deletion, the deletion began with codon 333 and ended at codon 355, suggesting that the deletion was not random.
High prevalence of EBV isolates carrying a 30-bp deletion in the LMP-1 gene is predominantly found in Asian populations, [35] [36] [37] but is rarely found in African and European populations. 36, 37 This deletion was detected in all the type A Chinese strains, but was not present in the type B Alaskan strains even though the Chinese and Alaskan strains were nearly identical within the amino terminus of LMP-1.
35
The occurrence of high frequency of the 69-bp deletion appears to have no correlation with the disease site (Table 3) . Since this is a retrospective study, with the present data it is difficult to correlate the sequence variations of LMP-1 with disease status. To ascertain the specific change characteristic for Turkish BL, we are in the process of collecting normal healthy donor and patient lymphocytes for evaluating the LMP-1 sequence.
It has been shown that the oncoprotein LMP-1 of EBV is essential for the transformation of B lymphocytes in vitro, 38 and is the only EBV-encoded protein capable of transforming rodent fibroblasts in culture. 21, 22 Analysis of the variation in natural isolates of EBV may identify amino acid domains that are critical for the transforming function of the protein and sequences that are variable because of selective pressure from the immune system.
Deletion studies have identified that the DNA sequences between amino acids 322 and 364 are required for rapid turnover of the LMP-1 protein. 39 The 30-bp deletion (amino acids 346-355) in the carboxy terminal of LMP-1, characteristic of Asian EBV strain, is located in this area and may, therefore, prolong the half-life of the LMP-1 protein and thereby promote a higher level of LMP-1 expression in the cells. 40 In the 19 BL cases in which LMP-1 isolates carrying deletions (either 30 bp or 69 bp) are located within amino acid positions 333-355, the same area affects the turnover of the LMP-1 protein.
Figure 5
Continued.
Recently, the EBV variants with 30-bp deletion in the LMP-1 has been frequently found in HIV-associated HD, Malaysian and Danish peripheral T cell lymphomas, lymphoroliferative disorders, in Brazilian BL and reactive lymphoid tissue, and in throat washings from patients with head and neck tumors in Taiwan. 33, [41] [42] [43] [44] These findings were taken to argue against the notion that EBV strain with the 30 bp-deleted LMP-1 can be used as simple markers for oncogenic viruses related to particular forms of EBV-associated tumors. 43 However, several studies indicate that the 30 bp-deleted LMP-1 may play a role in the oncogenic potential of EBV. 31, 32, 35, 42, [45] [46] [47] Ascertaining the role of the high prevalence of both 30-bp and 69-bp deletions in Turkish BL pathogenesis will require further study.
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